Document is current

Any future updates will be listed below

The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s40360-024-00740-y

Published Online: 2024-02-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark